Global Insights: Comparing Clinical Research Trials and Regulatory Pathways

Written By Julio G. Martinez-Clark

In the competitive world of clinical research, selecting the right country to conduct a study can significantly impact approval timelines and costs. In this blog, we offer a comprehensive comparison of the regulatory and hospital-related processes in eight key Latin American countries: Colombia, Argentina, Brazil, Mexico, Chile, Panama, Paraguay, and the Dominican Republic.

We will examine the approval timelines for clinical trials by the leading regulatory entities, such as INVIMA in Colombia, ANMAT in Argentina, COFEPRIS in Mexico, and CONABIOS in the Dominican Republic, among others. Additionally, we'll provide an analysis of hospital costs in each country, offering valuable insights for those looking to conduct clinical trials in the region.

Julio G. Martinez-Clark http://www.juliomartinezclark.com/
Previous

How to Navigate Medical Device Trials in the Dominican Republic
Next

Unlocking Chile's Potential: A Gateway to Clinical Research Excellence in Latin America